A clinical discussion published by Contemporary OB/GYN with endometriosis surgeon Dr. Lora Liu highlights the continuing importance of laparoscopy in the evaluation and management of selected patients with suspected endometriosis.

Modern high-resolution transvaginal ultrasonography and pelvic MRI have substantially improved non-invasive diagnosis, particularly for ovarian endometriomas, deep infiltrating disease, bowel involvement, and significant anatomical distortion. Nevertheless, imaging does not identify every manifestation of endometriosis.

Small superficial peritoneal implants, subtle disease and some forms of fibrosis or adhesions may remain difficult to characterize radiologically. Imaging can also underestimate the degree to which endometriosis has altered normal pelvic tissue planes.

Consequently, a normal or relatively limited imaging study does not always exclude clinically important disease when symptoms and physical findings remain strongly suggestive.

Laparoscopy Provides Information Beyond Diagnosis

The value of laparoscopy extends beyond simply confirming whether visible endometriotic lesions are present. Direct operative assessment allows the surgeon to evaluate:

• Distribution and extent of visible disease
• Pelvic adhesions and fibrosis
• Ovarian and tubal involvement
• Obliteration or distortion of the pouch of Douglas
• Relationship of disease to the rectum and sigmoid colon
• Bladder and ureteric involvement
• Mobility and preservation of pelvic organs
• Feasibility and complexity of complete surgical excision

This information can directly influence the operative strategy and the requirement for advanced gynecologic, colorectal or urological surgical support.

Surgical Relevance

The contemporary role of laparoscopy should not be interpreted as routine diagnostic surgery for every patient with pelvic pain. Rather, the decision should integrate symptoms, pelvic examination, imaging findings, previous treatment, fertility objectives, response to medical therapy and likelihood that operative findings will alter management.

For patients undergoing therapeutic surgery, detailed intraoperative mapping is particularly important because endometriosis can involve multiple anatomical compartments and may require advanced adhesiolysis, ureterolysis, ovarian reconstruction, bowel dissection or other complex procedures.

Clinical Takeaway: Modern imaging has greatly improved endometriosis diagnosis, but it cannot completely replace operative assessment in appropriately selected patients. When clinical symptoms, examination and imaging are discordant, laparoscopy can provide direct anatomical information while simultaneously allowing definitive surgical treatment when indicated.

Source: Contemporary OB/GYN – Lora Liu, MD, on Closing the Gaps in Endometriosis Care

Biodegradable 3D-Printed Gastric Stent Proposed for Management of Post-Bariatric Gastric Leaks

A report from HospiMedica describes BRIDGE, an experimental biodegradable 3D-printed gastric stent developed at NYU Abu Dhabi as a potential internal drainage solution for gastric leaks following bariatric surgery.

Postoperative leaks remain among the most challenging complications following procedures such as laparoscopic sleeve gastrectomy. Management may require combinations of drainage, nutritional support, antibiotics, endoscopic therapy and, in selected cases, surgical intervention.

Conventional endoscopic stents can provide effective diversion or drainage but may be associated with migration, intolerance, kinking, obstruction and the requirement for subsequent endoscopic removal.

Why a Biodegradable Stent Could Be Important

BRIDGE incorporates a 3D-printed lattice architecture intended to preserve internal drainage while maintaining flexibility within the angulated anatomy of the stomach.

Its biodegradable construction is particularly interesting because the device is designed to degrade after fulfilling its therapeutic function, potentially eliminating the need for a planned endoscopic procedure solely for stent removal.

Laboratory evaluation reportedly demonstrated encouraging drainage characteristics and flexibility compared with conventional stent designs. However, the technology remains at a preclinical engineering stage.

Surgical Relevance

Management of post-bariatric leaks is rarely solved by a single intervention. Treatment depends on the patient's physiological condition, timing and location of the leak, size of the defect, presence of collections, distal obstruction or sleeve stenosis, and effectiveness of source control.

A biodegradable internal-drainage platform could potentially reduce the number of repeated endoscopic interventions required during prolonged leak management.

For bariatric surgeons, the concept is particularly relevant because successful leak management increasingly depends upon close collaboration among laparoscopic bariatric surgeons, therapeutic endoscopists, interventional radiologists, nutrition teams and critical-care specialists.

Before clinical adoption, however, biodegradable stents will require evidence regarding:

• Biocompatibility and degradation characteristics
• Reliable duration of structural support
• Migration and obstruction risk
• Tissue reaction
• Leak-closure effectiveness
• Ability to manage complex gastric anatomy
• Rescue options if treatment fails
• Comparative effectiveness against established endoscopic therapies

Clinical Takeaway: A biodegradable 3D-printed gastric stent could eventually reduce repeat endoscopic procedures during management of post-bariatric leaks, but current evidence remains preclinical and clinical safety, effectiveness and degradation behavior must be established before routine use.

Source: HospiMedica – Biodegradable Gastric Stent for Bariatric Surgery Leaks

Key Message

The 29 August 2026 evidence update highlights two complementary directions in modern minimally invasive surgery. In endometriosis, increasingly sophisticated imaging must still be integrated with clinical judgment and direct laparoscopic anatomical assessment when non-invasive findings do not adequately explain the patient's disease. In bariatric surgery, advanced 3D printing and biodegradable biomaterials may eventually create new endoscopic solutions for difficult postoperative complications such as gastric leaks.

Together, these developments demonstrate that innovation in minimally invasive surgery does not always mean replacing established techniques. Sometimes progress comes from using laparoscopy more selectively and intelligently, while in other situations it comes from developing entirely new technologies capable of reducing the burden of repeated interventions.

The future of minimally invasive surgery lies in combining better diagnosis, precise patient selection, advanced operative judgment and responsibly validated technology to deliver safer and more individualized treatment.